Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
874 studies found for:    Open Studies | "Carcinoma, Non-Small-Cell Lung"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Carcinoma, Non-Small-Cell Lung"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Oshadi D and Oshadi R in Combination With Docetaxel, as 2nd Line Therapy for Metastatic Non Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Oshadi D and Oshadi R;   Drug: Docetaxel
2 Recruiting Aprepitant for Chemotherapy Induced Nausea and Vomiting in Chinese Advanced Non-small Cell Lung Cancers
Condition: Carcinoma, Non-small Cell Lung
Interventions: Drug: Aprepitant;   Drug: placebo
3 Recruiting Ethaselen for the Treatment of Thioredoxin Reductase High Expression Advanced Non-small Cell Lung Cancers
Condition: Carcinoma, Non-small Cell Lung
Intervention: Drug: ethaselen
4 Recruiting BIO 300 Non-Small Cell Lung Cancer Study
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: BIO 300 Oral Suspension;   Drug: Paclitaxel;   Drug: Carboplatin;   Radiation: Radiotherapy
5 Recruiting A Trial of AP32788 in Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: AP32788
6 Recruiting Crizotinib in Pretreated Metastatic Non-small-cell Lung Cancer With MET Amplification or ROS1 Translocation (METROS)
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Crizotinib
7 Not yet recruiting Durvalumab (MEDI4736) With or Without SBRT in Clinical Stage IB and II Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Durvalumab;   Other: Durvalumab plus SBRT
8 Recruiting Pemetrexed in Advanced Non-Small-Cell Lung Cancer: at Progression vs Maintenance Therapy After Induction Chemotherapy
Condition: Carcinoma, Non-small-cell Lung
Interventions: Drug: maintenance pemetrexed;   Drug: pemetrexed at progression
9 Recruiting A Pilot Study of Response-Driven Adaptive Radiation Therapy for Patients With Locally Advanced Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Radiation: Response-driven Adaptive Radiation Therapy;   Drug: Carboplatin;   Drug: Paclitaxel;   Device: FDG-PET;   Device: V/Q SPECT
10 Recruiting Single Agent Versus Combination Chemotherapy to Treat High-risk Elderly With Non-small Cell Lung Cancer
Condition: Carcinoma, Non-small Cell Lung
Interventions: Drug: Carboplatin;   Drug: Nab-paclitaxel
11 Recruiting Afatinib (BIBW 2992) in Advanced Non-Small Cell Lung Cancer Patients With EGFR Mutation
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Afatinib
12 Not yet recruiting MK-3475 in Combination With Docetaxel vs Docetaxel Alone in Non-Small Cell Lung Cancer Patients
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: MK-3475;   Drug: Docetaxel
13 Recruiting Phase 2 Study of Glesatinib, Sitravatinib or Mocetinostat in Combination With Nivolumab in Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Glesatinib;   Drug: Sitravatinib;   Drug: Mocetinostat;   Drug: Nivolumab
14 Recruiting Cisplatin-Pemetrexed Compared With Carboplatin-Paclitaxel-Bevacizumab in KRAS Mutated Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small Cell Lung
Interventions: Drug: carboplatin;   Drug: paclitaxel;   Drug: Bevacizumab;   Drug: Pemetrexed;   Drug: cisplatin
15 Recruiting Study of Pembrolizumab Versus Docetaxel in Participants Previously Treated for Non-Small Cell Lung Cancer (MK-3475-033)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Biological: pembrolizumab 2 mg/kg;   Drug: Docetaxel 75 mg/m^2
16 Recruiting BI 836845 Plus Afatinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: BI 836845;   Drug: afatinib
17 Recruiting Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200)
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Avelumab;   Drug: Docetaxel
18 Recruiting Investigation of the Effect of Nintedanib on the Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Patients With Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Microgynon;   Drug: Nintedanib
19 Not yet recruiting A Study of Napabucasin (BBI-608) Plus Weekly Paclitaxel Versus Weekly Paclitaxel Alone in Patients With Advanced, Previously Treated, Non-Squamous Non-Small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Napabucasin;   Drug: Paclitaxel
20 Recruiting Clinical Study of Oral cMET Inhibitor INC280 in Adult Patients With Advanced Non-small Cell Lung Cancer Who Have Received One or Two Prior Lines of Therapy
Condition: Carcinoma, Non-Small-Cell Lung
Intervention: Drug: INC280 (capmatinib)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.